These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28770640)

  • 1. Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.
    Cornett E; Novitch MB; Kaye AD; Pann CA; Bangalore HS; Allred G; Bral M; Jhita PK; Kaye AM
    Postgrad Med; 2017 Sep; 129(7):715-724. PubMed ID: 28770640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.
    Zambon A; Polo Friz H; Contiero P; Corrao G
    Drug Saf; 2009; 32(2):159-67. PubMed ID: 19236122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
    Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
    BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
    Trac MH; McArthur E; Jandoc R; Dixon SN; Nash DM; Hackam DG; Garg AX
    CMAJ; 2016 Apr; 188(7):E120-E129. PubMed ID: 26903359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities.
    Polgreen LA; Riedle BN; Cavanaugh JE; Girotra S; London B; Schroeder MC; Polgreen PM
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis.
    Pham Nguyen TP; Leonard CE; Bird SJ; Willis AW; Hamedani AG
    Muscle Nerve; 2021 Aug; 64(2):156-162. PubMed ID: 33719062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of macrolides with overall mortality and cardiac death among patients with various infections: A meta-analysis.
    Li X; Wang M; Liu G; Ma J; Li C
    Eur J Intern Med; 2016 Mar; 28():32-7. PubMed ID: 26412674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET 1: What is the incidence of cardiac arrhythmia in adult patients with acute infection prescribed fluoroquinolones?
    Chan K; Fitzpatrick J
    Emerg Med J; 2019 Oct; 36(10):635-638. PubMed ID: 31551305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-induced cardiac arrhythmias.
    Abo-Salem E; Fowler JC; Attari M; Cox CD; Perez-Verdia A; Panikkath R; Nugent K
    Cardiovasc Ther; 2014 Feb; 32(1):19-25. PubMed ID: 24428853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide antibiotics and the risk of cardiac arrhythmias.
    Albert RK; Schuller JL;
    Am J Respir Crit Care Med; 2014 May; 189(10):1173-80. PubMed ID: 24707986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions.
    Bonaldo G; Andriani LA; D'Annibali O; Motola D; Vaccheri A
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1457-1463. PubMed ID: 31423694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
    Inghammar M; Svanström H; Melbye M; Pasternak B; Hviid A
    BMJ; 2016 Feb; 352():i843. PubMed ID: 26920666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial use: a risk factor or a protective factor for acquiring campylobacteriosis?
    Koningstein M; Simonsen J; Helms M; Hald T; Mølbak K
    Clin Infect Dis; 2011 Oct; 53(7):644-50. PubMed ID: 21890769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient gatifloxacin therapy and dysglycemia in older adults.
    Park-Wyllie LY; Juurlink DN; Kopp A; Shah BR; Stukel TA; Stumpo C; Dresser L; Low DE; Mamdani MM
    N Engl J Med; 2006 Mar; 354(13):1352-61. PubMed ID: 16510739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone use and serious arrhythmias: A nationwide case-crossover study.
    Porta L; Lee MG; Hsu WT; Hsu TC; Tsai TY; Lee CC
    Resuscitation; 2019 Jun; 139():262-268. PubMed ID: 31029713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
    Altenburg J; de Graaff CS; van der Werf TS; Boersma WG
    Respiration; 2011; 81(1):75-87. PubMed ID: 20733282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
    Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
    Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
    Bidell MR; Lodise TP
    Pharmacotherapy; 2016 Jun; 36(6):679-93. PubMed ID: 27138564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.